Griffith Institute for Health and Medical Research, School of Dentistry and Oral Health, and School of Medicine, Griffith University, Queensland 4222, Australia.
Head Neck. 2011 Apr;33(4):566-72. doi: 10.1002/hed.21496.
Very few articles have been written about the expression of kallikreins (KLK4 and KLK7) in oral cancers. Therefore, the purpose of this study was to examine and report on their prognostic potential.
Eighty archival blocks of primary oral cancers were sectioned and stained for KLK4 and KLK7 by immunohistochemistry. The percentage and the intensity of malignant keratinocyte staining were correlated with patient survival using Cox regression analysis.
Both kallikreins were expressed strongly in the majority of tumor cells in 68 of 80 cases: these were mostly moderately or poorly differentiated neoplasms. Staining was particularly intense at the infiltrating front. Patients with intense staining had significantly shorter overall survival (p < .05).
This is the first observation on the patient survival influenced by kallikrein expression in oral carcinoma. The findings are consistent with those for carcinomas at other sites, in particular the prostate and ovary. KLK4 and/or KLK7 immunohistochemistry seems to have diagnostic and prognostic potential in this disease.
关于激肽释放酶(KLK4 和 KLK7)在口腔癌中的表达,鲜有文章论及。因此,本研究旨在探讨并报告其预后潜能。
对 80 例原发性口腔癌存档蜡块进行 KLK4 和 KLK7 的免疫组织化学检测。采用 Cox 回归分析,将恶性角质形成细胞染色的百分比和强度与患者生存相关联。
在 80 例中的 68 例中,两种激肽释放酶在大多数肿瘤细胞中均呈强阳性表达:这些肿瘤多为中或低分化肿瘤。染色在浸润前沿尤为强烈。染色强度高的患者总生存率显著缩短(p <.05)。
这是首次观察到激肽释放酶在口腔癌中表达对患者生存的影响。这些发现与其他部位的癌症(特别是前列腺癌和卵巢癌)的结果一致。KLK4 和/或 KLK7 的免疫组织化学检测在该疾病中似乎具有诊断和预后潜能。